INTERLEUKIN-13 - NOVEL ROLE IN DIRECT REGULATION OF PROLIFERATION AND DIFFERENTIATION OF PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS

被引:48
作者
JACOBSEN, SEW
OKKENHAUG, C
VEIBY, OP
CAPUT, D
FERRARA, P
MINTY, A
机构
[1] HAFSLUND NYCOMED BIOREG,N-0371 OSLO,NORWAY
[2] SANOFI ELF BIO RECH,F-31676 LABEGE,FRANCE
关键词
D O I
10.1084/jem.180.1.75
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The recently cloned interleukin 13 (IL-13) shares most investigated biological activities on B lymphocytes and monocytes with IL-4. In this study we investigated for the first time the potential role of IL-13 in the regulation of the growth of hematopoietic progenitor cells. IL-13 enhanced stem cell factor (SCF)-induced proliferation of Lin(-)Sca-1(+) bone marrow progenitor cells more potently than IL-4. The effect of IL-13 was purely synergistic, since IL-13 alone stimulated no colony formation. Single cell experiments suggested that the synergistic effect of IL-13 on Lin(-)Sca-1(+) progenitors was directly mediated. In contrast, IL-13 had no synergistic activity on SCF-induced proliferation of the more mature Lin(-)Sca-1(-) progenitor cells. Thus, the cloning frequency in response to SCF + IL-13 was at least 20-fold higher in the Lin(-)Sca-1(+) than the Lin(-)Sca-1(-) progenitor cell population. Furthermore, IL-13 but not IL-4 synergistically enhanced colony formation of Lin(-)Sca(-)1(+) progenitors in response to granulocyte/macrophage colony-stimulating factor (GM-CSF) (threefold), whereas both IL-4 and IL-13 enhanced G-CSF-induced colony formation (threefold), and neither of the two significantly affected CSF-1 and IL-3-induced proliferation. Finally, whereas stimulation of Lin(-)Sca-1( )progenitors by SCF + G-CSF resulted in the formation of 90% granulocytes, the addition of IL-13 resulted in the production of macrophages exclusively. This novel effect on differentiation was directly mediated, shared with IL-4, and could not be observed on Lin(-)Sca-1(-) progenitor cells. Collectively, these findings indicate a novel role of IL-13 in early myelopoiesis, partially overlapping but also different from that of IL-4.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 39 条
[11]   RHODAMINE-123 REVEALS HETEROGENEITY WITHIN MURINE LIN-, SCA-1+ HEMATOPOIETIC STEM-CELLS [J].
LI, CL ;
JOHNSON, GR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) :1443-1447
[12]  
LOWRY PA, 1992, BLOOD, V80, P663
[13]   INTERLEUKIN-13, A T-CELL-DERIVED CYTOKINE THAT REGULATES HUMAN MONOCYTE AND B-CELL FUNCTION [J].
MCKENZIE, ANJ ;
CULPEPPER, JA ;
MALEFYT, RD ;
BRIERE, F ;
PUNNONEN, J ;
AVERSA, G ;
SATO, A ;
DANG, W ;
COCKS, BG ;
MENON, S ;
DEVRIES, JE ;
BANCHEREAU, J ;
ZURAWSKI, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3735-3739
[14]   DIRECT PROLIFERATIVE ACTIONS OF STEM-CELL FACTOR ON MURINE BONE-MARROW CELLS-INVITRO - EFFECTS OF COMBINATION WITH COLONY-STIMULATING FACTORS [J].
METCALF, D ;
NICOLA, NA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6239-6243
[15]   CONTROL OF GRANULOCYTES AND MACROPHAGES - MOLECULAR, CELLULAR, AND CLINICAL ASPECTS [J].
METCALF, D .
SCIENCE, 1991, 254 (5031) :529-533
[16]  
METCALF D, 1984, HEMOPOIETIC COLONIES
[17]   INTERLEUKIN-13 IS A NEW HUMAN LYMPHOKINE REGULATING INFLAMMATORY AND IMMUNE-RESPONSES [J].
MINTY, A ;
CHALON, P ;
DEROCQ, JM ;
DUMONT, X ;
GUILLEMOT, JC ;
KAGHAD, M ;
LABIT, C ;
LEPLATOIS, P ;
LIAUZUN, P ;
MILOUX, B ;
MINTY, C ;
CASELLAS, P ;
LOISON, G ;
LUPKER, J ;
SHIRE, D ;
FERRARA, P ;
CAPUT, D .
NATURE, 1993, 362 (6417) :248-250
[18]  
MOORE MAS, 1991, BLOOD, V78, P1
[19]   T-CELL AND MAST-CELL LINES RESPOND TO B-CELL STIMULATORY FACTOR-I [J].
MOSMANN, TR ;
BOND, MW ;
COFFMAN, RL ;
OHARA, J ;
PAUL, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (15) :5654-5658
[20]   PROLIFERATION AND DIFFERENTIATION OF HIGHLY ENRICHED MOUSE HEMATOPOIETIC STEM-CELLS AND PROGENITOR CELLS IN RESPONSE TO DEFINED GROWTH-FACTORS [J].
MULLERSIEBURG, CE ;
TOWNSEND, K ;
WEISSMAN, IL ;
RENNICK, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (06) :1825-1840